Investing Profile
Markus Goebel
Advisor
Biotech & Medtech consulting
Switzerland
Your Intro Paths to Markus Goebel
Signal uses Gmail to reveal intro paths. Email content is never read.
Sign in with Google →Networks Markus is a member of
Novartis Network
53 CONNECTIONS
Novartis Network
53 CONNECTIONS
Roche Network
31 CONNECTIONS
Novartis Venture Fund Network
11 CONNECTIONS
Find Markus Goebel on
cbCurrent Investing Position
Advisor
Investments On Record
5
Markus Goebel is on these Sector & Stage Rankings
Markus Goebel's Investments On Record (3)
| Company | StageDateRound Size | Total Raised |
|---|---|---|
Merganser Biotech | Series AFeb 2015$28M | $28M |
Sorbent Therapeutics | Series DMay 2014$7M Series CAug 2012$18M Series BJun 2011$36M | $86M |
Trellis Bioscience | Series BFeb 2007$10M | $10M |
Markus Goebel's Experience
Expert Innosuisse2022 - Present
CEO M&G Advisors GmbH2019 - Present
Director HAYA Therapeutics SA2020 - 2020
Managing Director Novartis Venture Fund2004 - 2019
Head Pharma Corporate M&A Novartis2002 - 2004
Head Nervous System BD&L Pharma Novartis2000 - 2002
Several Marketing & Strategy positions incl. an alliance with Amgen Roche1992 - 1999
Medical Manager Oncology & Medical Science FARMITALIA CARLO ERBA LIMITED1990 - 1992
Markus Goebel's Education
Henley Management College MBA
Ludwig-Maximilians Universität München MD
Henley Business School Master of Business Administration - MBA
Ludwig-Maximilians Universität München Doctor of Medicine - MD
University of Hamburg PhD ADPRibosylation
Founders who looked at Markus Goebel's profile also looked at these Investors
Founders who looked at Markus Goebel's profile also looked at these Scouts & Angels